Colorectal Cancer Therapeutics Market Emerging Technologies, Regional Trend, Growth, Forecast to 2026

1
Colorectal Cancer Therapeutics Market Size, Share
Industry Analysis, By Therapy (Targeted
Therapy, Immunotherapy, Chemotherapy, Others), By
Cancer Type (Colorectal Adenocarcinoma,
Gastrointestinal Carcinoid Tumors, Others), By
Distribution Channel (Hospitals Pharmacies,
Retail Pharmacies, Online Pharmacies, Others) and
Regional Forecast, 2019-2026
Buy Now
Sample PDF
Get Discount
Published Date April 2019 Report Format PDF
Region Global Base Year 2018
2
Colorectal Cancer Therapeutics Market Size, Share
Industry Analysis, By Therapy (Targeted
Therapy, Immunotherapy, Chemotherapy, Others), By
Cancer Type (Colorectal Adenocarcinoma,
Gastrointestinal Carcinoid Tumors, Others), By
Distribution Channel (Hospitals Pharmacies,
Retail Pharmacies, Online Pharmacies, Others) and
Regional Forecast, 2019-2026
Report Highlights The global colorectal cancer
therapeutics market size is projected to reach
USD 16.58 billion by 2026, owing to the rise in
the prevalence of colorectal cancer worldwide. A
report by Fortune Business Insights titled,
Colorectal Cancer Therapeutics Market Size,
Share Industry Analysis, By Therapy (Targeted
Therapy, Immunotherapy, Chemotherapy, Others), By
Cancer Type (Colorectal Adenocarcinoma,
Gastrointestinal Carcinoid Tumors, Others), By
Distribution Channel (Hospitals Pharmacies,
Retail Pharmacies, Online Pharmacies, Others) and
Regional Forecast, 2019-2026, provides a
detailed analysis of the same. According to the
report, the colorectal cancer drugs market was
valued at USD 9.26 billion in 2018. The forecast
period is set from 2019 to 2026, and the market
is likely to exhibit a CAGR of 7.6. As per
current colorectal cancer therapeutics market
trends, the targeted therapy segment is
dominating the market in terms of therapy. This
is attributed to the presence of a large number
of prominent targeted cancer therapies such as
Stivarga, Erbitux, and Avastin.
3
Colorectal Cancer Therapeutics Market Size, Share
Industry Analysis, By Therapy (Targeted
Therapy, Immunotherapy, Chemotherapy, Others), By
Cancer Type (Colorectal Adenocarcinoma,
Gastrointestinal Carcinoid Tumors, Others), By
Distribution Channel (Hospitals Pharmacies,
Retail Pharmacies, Online Pharmacies, Others) and
Regional Forecast, 2019-2026
Launch of Better Therapeutics for Colorectal
Cancer to Aid in Expansion of Market The rise in
awareness about colorectal cancer is a major
factor driving the colorectal cancer therapeutics
market growth. Additionally, the increasing
number of corresponding product launches for
effective colorectal cancer treatment is further
expected to help increase the overall market
growth in the forecast period. Moreover, the
advent of the latest initiatives aiming to
provide effective care of colorectal cancer
patients is more likely to aid in the expansion
of the market for colorectal cancer drugs.
Furthermore, the high mortality rates, coupled
with the rising demand for effective cancer
therapeutics worldwide, is prognosticated to have
a positive effect on the colorectal cancer
medications market size in the forthcoming
years. Rise in Disposable Incomes and Increasing
Awareness about Therapeutic Procedures to Help
Asia Pacific Witness Rapid Growth Geographically,
North America is leading the market with a high
prevalence of colorectal cancer. In 2018, North
America earned USD 4.13 billion, owing to the new
product launches in and around the region. Thus,
the factors mentioned above are likely to help
this region continue dominating the market in the
future too. Browse Complete Report
Details https//www.fortunebusinessinsights.com/i
ndustry-reports/colorectal-cancer-therapeutics-mar
ket-101945
4
Colorectal Cancer Therapeutics Market Size, Share
Industry Analysis, By Therapy (Targeted
Therapy, Immunotherapy, Chemotherapy, Others), By
Cancer Type (Colorectal Adenocarcinoma,
Gastrointestinal Carcinoid Tumors, Others), By
Distribution Channel (Hospitals Pharmacies,
Retail Pharmacies, Online Pharmacies, Others) and
Regional Forecast, 2019-2026

• List of the companies functioning in the global
  market are
• Novartis AG
• Bayer AG
• Merck Sharp Dohme Corp.
• Bristol Myers Squibb
• Pfizer Inc.
• Genentech, Inc.
• Ipsen Biopharmaceuticals, Inc.
• Regeneron Pharmaceuticals, Inc.
• Taiho Pharmaceutical (Otsuka Pharmaceutical Co.,
  Ltd.)
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• Eli Lilly and Company
• Get Customization
• https//www.fortunebusinessinsights.com/enquiry/sp
  eak-to-analyst/colorectal-cancer-therapeutics-mark
  et-101945 

5
Colorectal Cancer Therapeutics Market Size, Share
Industry Analysis, By Therapy (Targeted
Therapy, Immunotherapy, Chemotherapy, Others), By
Cancer Type (Colorectal Adenocarcinoma,
Gastrointestinal Carcinoid Tumors, Others), By
Distribution Channel (Hospitals Pharmacies,
Retail Pharmacies, Online Pharmacies, Others) and
Regional Forecast, 2019-2026
About Us Fortune Business Insights offers expert
corporate analysis and accurate data, helping
organizations of all sizes make timely decisions.
We tailor innovative solutions for our clients,
assisting them to address challenges distinct to
their businesses. Our goal is to empower our
clients with holistic market intelligence, giving
a granular overview of the market they are
operating in.    Our reports contain a unique mix
of tangible insights and qualitative analysis to
help companies achieve sustainable growth. Our
team of experienced analysts and consultants use
industry-leading research tools and techniques to
compile comprehensive market studies,
interspersed with relevant data.    Phone US 1
424 253 0390 UK 44 2071 939123 APAC 91 744
740 1245 Email sales_at_fortunebusinessinsights.com